Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy

被引：0
|
作者：
Daniel J. Przybylski
David J. Reeves
机构：
[1] Butler University,College of Pharmacy and Health Sciences
[2] St. Vincent Indianapolis Hospital,Department of Pharmacy
来源：
Supportive Care in Cancer | 2017年 / 25卷
关键词：
Fluoroquinolone prophylaxis; Febrile neutropenia; Acute myeloid leukemia; Moxifloxacin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3715 / 3721
页数：6
相关论文
共 50 条
  • [21] Levofloxacin for febrile neutropenia prophylaxis in acute myeloid leukemia patients associated with reduction in hospital admissions
    Samantha S. F. Lee
    Adrienne E. Fulford
    Maureen A. Quinn
    Jamie Seabrook
    Irina Rajakumar
    Supportive Care in Cancer, 2018, 26 : 1499 - 1504
  • [22] Levofloxacin for febrile neutropenia prophylaxis in acute myeloid leukemia patients associated with reduction in hospital admissions
    Lee, Samantha S. F.
    Fulford, Adrienne E.
    Quinn, Maureen A.
    Seabrook, Jamie
    Rajakumar, Irina
    SUPPORTIVE CARE IN CANCER, 2018, 26 (05) : 1499 - 1504
  • [23] Risk of Severe Dysglycemia among Outpatient Receiving Levofloxacin, Ciprofloxacin or Moxifloxacin in Taiwan
    Chou, Hsu-Wen
    Shau, Wen-Yi
    Lee, Jen-Jyh
    Chang, Chia-Hsuin
    Lai, Mei-Shu
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S285 - S286
  • [24] LEVOFLOXACIN VERSUS CIPROFLOXACIN PROPHYLAXIS IN PEDIATRIC CANCER PATIENTS AT HIGH RISK OF INFECTION
    Dargan, Chandni
    Bartholomew, Joy
    Johnson, Amy
    Klockau, Christopher
    Burns, Alaina
    Schuster, Jennifer
    Gamis, Alan
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S47 - S48
  • [25] Cost-effectiveness of levofloxacin prophylaxis against bacterial infection in pediatric patients with acute myeloid leukemia
    McCormick, Meghan
    Friehling, Erika
    Kalpatthi, Ramasubramanian
    Siripong, Nalyn
    Smith, Kenneth
    PEDIATRIC BLOOD & CANCER, 2020, 67 (10)
  • [26] Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis
    Richard, GA
    Klimberg, IN
    Fowler, CL
    Callery-D'Amico, S
    Kim, SS
    UROLOGY, 1998, 52 (01) : 51 - 55
  • [27] SEIFEM 2010-E: economic evaluation of posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia receiving induction chemotherapy
    Busca, Alessandro
    Lessi, Federica
    Verga, Luisa
    Candoni, Anna
    Cattaneo, Chiara
    Cesaro, Simone
    Dragonetti, Giulia
    Delia, Mario
    De Luca, Alessio
    Guglielmi, Gaspare
    Tumbarello, Mario
    Martino, Giordana
    Nadali, Gianpaolo
    Fanci, Rosa
    Picardi, Marco
    Potenza, Leonardo
    Nosari, Annamaria
    Aversa, Franco
    Pagano, Livio
    LEUKEMIA & LYMPHOMA, 2017, 58 (12) : 2859 - 2864
  • [28] Comparable Efficacy and Safety with Voriconazole or Posaconazole as Primary Antifungal Prophylaxis in Acute Myeloid Leukemia (AML) Patients Receiving Induction Chemotherapy
    Wetzstein, Gene A.
    George, Timothy J.
    Sharifi, Mahsa
    Hoang, Van D.
    Ho, Viet Q.
    Quilitz, Rod E.
    Spears, Dana A.
    Komrokji, Rami S.
    List, Alan F.
    Lancet, Jeffrey E.
    Greene, John N.
    BLOOD, 2009, 114 (22) : 813 - 813
  • [29] Severity of and contributors to distress in patients with acute myeloid leukemia (AML) receiving induction chemotherapy
    LeBlanc, Thomas William
    Wolf, Steven Paul
    Davis, Debra M.
    Samsa, Greg
    Locke, Susan C.
    El-Jawahri, Areej
    Tulsky, James A.
    Abernethy, Amy P.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (29)
  • [30] An Immune Risk Score Predicts Survival of Patients with Acute Myeloid Leukemia Receiving Chemotherapy
    Wang, Yun
    Cai, Yan-yu
    Herold, Tobias
    Nie, Run-cong
    Zhang, Yu
    Gale, Robert Peter
    Metzeler, Klaus H.
    Zeng, Yun
    Wang, Shun-qing
    Pan, Xue-yi
    Yang, Tong-hua
    Wu, Yuan-bin
    Zhang, Qing
    Wuxiao, Zhi-jun
    Du, Xin
    Liang, Zhi-wei
    Su, Yong-zhong
    Xu, Jing-bo
    Wang, Yong-qing
    Liu, Ze-lin
    Wu, Jian-wei
    Zhang, Xiong
    Wu, Bing-yi
    Xiao, Ruo-zhi
    Wang, San-bin
    Li, Jin-yuan
    Chi, Pei-dong
    Zhang, Qian-yi
    Chen, Si-liang
    Qin, Zhe-yuan
    Zhang, Xin-mei
    Zhong, Na
    Hiddemann, Wolfgang
    Liu, Qi-fa
    Zhang, Bei
    Liang, Yang
    CLINICAL CANCER RESEARCH, 2021, 27 (01) : 255 - 266
12345